- Home
- Media Center
- Press releases
- Innovative Medicine
Innovative Medicine
Janssen Healthcare Innovation Launches Care4Today™ Mobile Health Manager 2.0
Free two-way secure messaging platform, mobile app and website introduces new Care4Charity™ and Care4Family™ features to motivate users to take medications on schedule and support caregivers
STELARA® Receives European Commission Approval For Treatment Of Active Psoriatic Arthritis
Approval marks a new biologic treatment with alternative mechanism for complex inflammatory disease
SIMPONI® Receives European Commission Approval For Treatment Of Moderately To Severely Active Ulcerative Colitis
First and Only Subcutaneous Biologic Treatment Administered Every Four Weeks Approved for Ulcerative Colitis
STELARA® (Ustekinumab) Receives FDA Approval To Treat Active Psoriatic Arthritis
First and Only Anti-IL-12/23 Treatment Approved for Adult Patients Living with Psoriatic Arthritis
Pooled Analysis Confirms XARELTO® has Similar Efficacy and Reduces the Incidence of Major Bleeding by Nearly Half Compared to Standard of Care in Treatment of DVT and PE
Analysis Published in the Thrombosis Journal
Johnson & Johnson Completes Acquisition Of Aragon Pharmaceuticals, Inc.
Late-Stage Prostate Cancer Treatment Strengthens Oncology Pipeline
European Commission Approves VELCADE® As A Frontline Induction Therapy Before Stem Cell Transplantation
Decision could significantly improve transplant outcomes for patients with multiple myeloma